b'INDUSTRY NEWSAltasciencesissupportingmultiple COVID-19 related projects for vaccines, monoclonalantibodies,newsmall molecules,aswellasrepurposed generics, and we are in discussions on many more programs. Altasciencesteamofexpertsplannedforpotentialshortagesof nonhuman primate (NHP) supply for safety assessment studies, and took action to guarantee access.Altasciences entered into a four-year agreement to secure Cambodian primates. Read more AltascienceshascompletedaPhaseIstudyforthedevelopment ofgimsilumab,afullyhumanmonoclonalantibodythattargets granulocyte-macrophage colony stimulating factor (GM-CSF), found tobeup-regulatedinSARSCoV-2inpatientswithoratriskof developing acute respiratory distress syndrome (ARDS), with partner Roivant Sciences. Read more To see other ways Altasciences has responded to the pandemic, visit our COVID-19 page here.'